正文 淫羊藿總黃酮的生物轉化過程分析(3 / 3)

[4] Chen Y, Wang J Y, Jia X B, et al. Role of intestinal hydrolase in the absorption of prenylated flavonoids present in Yinyanghuo[J]. Molecules, 2011, 16: 1336.

[5] 陳彥,賈曉斌,譚曉斌,等. 大鼠在體腸灌流模型研究淫羊藿不同黃酮苷的吸收代謝[J]. 中國中藥雜誌, 2009, 34(22): 2928.

[6] 賈曉斌,蘭雪蓮,陳彥,等. 淫羊藿黃酮類成分抗骨質疏鬆作用及其機製研究進展[J]. 中國藥房, 2010, 21(3): 269.

[7] 楊乾栩,劉豔秋,王莉,等. 基於模型群體分析的淫羊藿抗骨質疏鬆活性成分篩選研究[J]. 藥學學報, 2012, 47(9): 1205.

[8] Wang Y, Harvey C B, Hollox E J, et al. The genetically programmed down-regulation of lactase in children[J]. Gastroenterology, 1998, 114: 1230.

[9] Bacsi K, Kosa J P, Balla B, et al. The decreased activity of lactase phlorizin hydrolase and bone mineral density in postmenopausal women[J]. J Bone Miner Res, 2007, 22: 186.

[10] 崔莉,張振海,孫娥,等. 柚皮苷-羥丙基-β-環糊精包合物酶解製備柚皮素工藝的研究[J]. 中國中藥雜誌, 2012, 37(3): 310.

[11] 賈東升,賈曉斌,薛璟,等. 蝸牛酶轉化淫羊藿苷製備淫羊藿苷元的研究[J]. 中國中藥雜誌, 2010, 35(7): 857.

[12] 平其能. 中藥成分的胃腸道轉運與劑型設計[M]. 北京:化學工業出版社, 2010: 32.

[13] 陳彥,賈曉斌,譚曉斌,等. 大鼠腸道水解酶對淫羊藿黃酮苷的處置影響[J]. 中國中藥雜誌, 2010, 45(7): 516.

[14] Chen Y, Wang J Y, Jia X B, et al. Role of intestinal hydrolase in the absorption of prenylated flavonoids present in Yinyanghuo[J]. Molecules, 2011, 16: 1336.

Analysis on biotransformation of Epimedium brevicornu flavonoids

GAO Xia1, 2, LIU Xuan1, 2, CHEN Yan1*, WANG Ying1, JIA Xiao-bin1

(1. Key Laboratory of New Type Drug Administration System of Traditional Chinese Medicines of

Jiangsu Provincial Academy of Chinese Medicine, Key Laboratory of Drug Release System of Oral

Traditional Chinese Medicine Preparations under State Administration of Traditional Chinese Medicine, Nanjing , China;

2. Nanjing University of Chinese Medicine, Jiangsu , China)

[Abstract] This study aims to investigate the biotransformation of Epimedium brevicornu flavonoids under the effect of hydrolytic enzymes in vitro. Snailase was mainly used to hydrolyze E.brevicornu flavonoids, and HPLC was used to determine the content of the main flavonoids in E.brevicornu flavonoids. The data results showed that the main known flavonoids included icariin, epimedin A, epimendin B and epimendin C, which were completely transformed into baohuoside I, sagittatoside A, sagittatoside B and 2″-O-rhamnosylicariside II in 1-2 h, respectively. Their transformed products were continuously hydrolyzed over time. In conclusion, snailase could transform E.brevicornu flavonoids into secondary glycoside or aglycone under 37 ℃ in pH 6.0 HBSS balanced salt solution in 2 h. Moreover, its enzymatic hydrolysates were consistent with intestinal metabolites.

[Key words] Epimedium brevicornu flavonoids; snailase; biotransformation

doi:10.4268/cjcmm